Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

2.61
Delayed Data
As of 3:59pm ET
 +0.06 / +2.35%
Today’s Change
1.94
Today|||52-Week Range
4.38
+9.66%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close2.55
Today’s open2.61
Day’s range2.53 - 2.61
Volume699,657
Average volume (3 months)1,026,163
Market cap$312.2M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-25.86%
Earnings growth (this year)+21.92%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-29.46%
P/E ratioNM
Price/Sales11.02
Price/Book4.60

Competitors

 Today’s
change
Today’s
% change
MRUSMerus NV0.000.00%
SELBSelecta Biosciences ...0.000.00%
MRSNMersana Therapeutics...-0.14-0.99%
EDGEEdge Therapeutics In...-0.11-1.05%
Data as of 3:59pm ET, 07/21/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$20.4M
Annual profit (last year)-$69.2M
Net profit margin-339.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts